Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Unveiling Significance of Time in Range: Value as key Glycemic Biomarker

Unveiling Significance of Time in Range: Value as key Glycemic Biomarker

Need to redefine the treatment paradigm Post OAD

Need to redefine the treatment paradigm Post OAD

SoliCGM Synergy: Soliqua’s Synchronized Impact on T2DM CGM Dynamics Therapy

SoliCGM Synergy: Soliqua’s Synchronized Impact on T2DM CGM Dynamics Therapy

The Evolving Role of Treatment and Technology in Diabetes Care

The Evolving Role of Treatment and Technology in Diabetes Care

Time-in-Range: A Key Determinant of Quality of Life

Time-in-Range: A Key Determinant of Quality of Life

The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

What Are the Signs and Symptoms of ASMD?

What Are the Signs and Symptoms of ASMD?

An Evidence about The Role of Basal Insulin Glargine 300 U/mL Post-GLP-1 Therapy

An Evidence about The Role of Basal Insulin Glargine 300 U/mL Post-GLP-1 Therapy

Connectivity Canvas: Pioneering Diabetes Management with Connected Insulin Caps

Connectivity Canvas: Pioneering Diabetes Management with Connected Insulin Caps

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.

Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens

Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens

An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.

Gaucher

Gaucher